Brief: BioInvent Q3 Adj. EPS at SEK -1.08

BioInvent International AB

26/10/2023 07:05

Oct 26 (Reuters) - BioInvent Q3 sales SEK 26.8 million.
* Q3 adjusted EPS SEK -1.08
* Q3 net income SEK -71.1 million
* Q3 adjusted free cash flow SEK -106.2 million